Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amino Up is a Japanese biotechnology company, with regional operations including Amino Up Hong Kong Biotechnology, that specializes in the development and manufacture of evidence-based functional natural compounds. The company is globally recognized for its flagship product, AHCC (Active Hexose Correlated Compound), a standardized extract of cultured Lentinula edodes mycelia used extensively in integrative oncology and immune health. Their portfolio also includes Oligonol, a highly bioavailable low-molecular-weight polyphenol derived from lychee fruit and green tea. Amino Up distinguishes itself through a rigorous commitment to clinical research, collaborating with over 100 academic institutions worldwide to validate the efficacy and safety of its nutraceutical ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amino Up Hong Kong Biotechnology.